Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | LIG1 | P18858 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL360102 | 0.98 | CYP2C9 (0.55) | CYP2C9CYP2C19CHRNB2CHRNB4CHRNA3 | |
| Phosphoric Acid SCHEMBL27561421 | 0.90 | CYP2C9 (0.47) | CYP2C9CYP2C19CHRNB2CHRNB4CHRNA3 | |
| Ethylene SCHEMBL173233 | 0.88 | AOC3 (0.52) | CHRNB2CHRNB4CHRNA3CHRNA4CA12 | |
| SCHEMBL11870125 | 0.87 | CYP2C9 (0.46) | CYP2C9CYP2C19CHRNB2CHRNB4CHRNA3 | |
| Bicarbonate SCHEMBL8928177 | 0.86 | THRB (0.53) | CHRNB2CHRNB4CHRNA3CHRNA4CA12 | |
| Formaldehyde SCHEMBL4291618 | 0.86 | CA12 (0.53) | CHRNB2CHRNB4CHRNA3CHRNA4CA12 | |
| SCHEMBL88417 | 0.86 | AOC3 (0.54) | CHRNB2CHRNB4CHRNA3CHRNA4CA12 | |
| SCHEMBL16371575 | 0.86 | AOC3 (0.54) | CHRNB2CHRNB4CHRNA3CHRNA4CA12 | |
| Sulfuric Acid SCHEMBL2938997 | 0.85 | CA12 (0.54) | CHRNB2CHRNB4CHRNA3CHRNA4CA12 | |
| Phosphoric Acid SCHEMBL28106043 | 0.85 | CA12 (0.50) | CYP2C9CYP2C19CHRNB2CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020230706-A1 | AQUEOUS LIQUID COSMETIC | ジェイオーコスメティックス株式会社 | 2020-11-19 | — | — | WO | disclosed |
| EP-2711404-B1 | ULTRAVIOLET SHIELDING AGENT, METHOD FOR PRODUCING SAME, ULTRAVIOLET SHIELDING AGENT-CONTAINING DISPERSION LIQUID, AND COSMETIC PREPARATION | SUMITOMO OSAKA CEMENT CO LTD (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-9326920-B2 | Ultraviolet-shielding agent, method for producing the same, ultraviolet-shielding agent-containing dispersion liquid, and cosmetic preparation | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20140086966-A1 | ULTRAVIOLET-SHIELDING AGENT, METHOD FOR PRODUCING THE SAME, ULTRAVIOLET-SHIELDING AGENT-CONTAINING DISPERSION LIQUID, AND COSMETIC PREPARATION | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2014-03-27 | — | — | US | disclosed |
| EP-2711404-A1 | ULTRAVIOLET SHIELDING AGENT, METHOD FOR PRODUCING SAME, ULTRAVIOLET SHIELDING AGENT-CONTAINING DISPERSION LIQUID, AND COSMETIC PREPARATION | Sumitomo Osaka Cement Co., Ltd. (JP) | 2014-03-26 | — | — | EP | disclosed |
| US-6258857-B1 | CHEMICAL FOR DISPENSING, DISPERSE SOLUTION, ACRYLIC ACID POLYMER AND ALKALI WITH SILICA | KYOWA INDUSTRIAL CO., LTD. (JP) | 2001-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140086966-A1 | ULTRAVIOLET-SHIELDING AGENT, METHOD FOR PRODUCING THE SAME, ULTRAVIOLET-SHIELDING AGENT-CONTAINING DISPERSION LIQUID, AND COSMETIC PREPARATION | ERCC4, ERCC1, XPA | CYP2C9 2346/4885CYP2C19 2801/4885CHRNB2 3938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.